82_FR_49034 82 FR 48832 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

82 FR 48832 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 202 (October 20, 2017)

Page Range48832-48832
FR Document2017-22825

Federal Register, Volume 82 Issue 202 (Friday, October 20, 2017) 
[Federal Register Volume 82, Number 202 (Friday, October 20, 2017)]
[Notices]
[Page 48832]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-22825]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Evaluation and Testing Services for 
Vaccines and Other Biologics for Diseases (N01).
    Date: November 14, 2017.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Annie Walker-Abbey, Ph.D., Scientific Review 
Officer, Scientific Review Program, NIAID/NIH/DHHS, 5601 Fishers 
Lane, Room 3E70A, Rockville, MD 20852, 240-627-3390, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: October 17, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-22825 Filed 10-19-17; 8:45 am]
 BILLING CODE 4140-01-P

48832 Federal Register / Vol. 82, No. 202 / Friday, October 20, 2017 / Notices Scientific Review, National Institutes of Dated: October 17, 2017. DEPARTMENT OF HEALTH AND Health, 6701 Rockledge Drive, Room 3192, Anna Snouffer, HUMAN SERVICES MSC 7808, Bethesda, MD 20892, 301–435– Acting Director, Office of Federal Advisory 1149, marci.scidmore@nih.gov. National Institutes of Health Committee Policy. Name of Committee: Center for Scientific [FR Doc. 2017–22824 Filed 10–19–17; 8:45 am] Review Special Emphasis Panel; PAR: National Cancer Institute; Notice of Development of Appropriate Pediatric BILLING CODE 4140–01–P Closed Meetings Formulations and Pediatric Drug Delivery Systems. Pursuant to section 10(d) of the Date: November 17, 2017. DEPARTMENT OF HEALTH AND Federal Advisory Committee Act, as Time: 2:00 p.m. to 5:00 p.m. HUMAN SERVICES amended, notice is hereby given of the Agenda: To review and evaluate grant following meetings. applications. National Institutes of Health The meetings will be closed to the Place: Residence Inn Arlington Pentagon public in accordance with the City, 550 Army Navy Drive, Arlington, VA National Institute of Allergy and provisions set forth in sections 22202. Infectious Diseases; Notice of Closed 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Contact Person: Joseph G. Rudolph, Ph.D., Meeting as amended. The grant applications and Chief and Scientific Review Officer, Center the discussions could disclose for Scientific Review, National Institutes of Pursuant to section 10(d) of the confidential trade secrets or commercial Health, 6701 Rockledge Drive, Room 5186, property such as patentable material, Federal Advisory Committee Act, as MSC 7844, Bethesda, MD 20892, 301–408– and personal information concerning 9098, josephru@csr.nih.gov. amended, notice is hereby given of the following meeting. individuals associated with the grant (Catalogue of Federal Domestic Assistance applications, the disclosure of which Program Nos. 93.306, Comparative Medicine; The meeting will be closed to the would constitute a clearly unwarranted 93.333, Clinical Research, 93.306, 93.333, public in accordance with the invasion of personal privacy. 93.337, 93.393–93.396, 93.837–93.844, provisions set forth in sections 93.846–93.878, 93.892, 93.893, National Name of Committee: National Cancer 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Institute Initial Review Group; Subcommittee Institutes of Health, HHS) as amended. The contract proposals and A—Cancer Centers. Dated: October 13, 2017. the discussions could disclose Date: November 30–December 1, 2017. Anna Snouffer, confidential trade secrets or commercial Time: 6:00 p.m. to 2:25 p.m. property such as patentable material, Agenda: To review and evaluate grant Deputy Director, Office of Federal Advisory applications. Committee Policy. and personal information concerning Place: Cambria Suites Rockville, 1 Helen [FR Doc. 2017–22725 Filed 10–19–17; 8:45 am] individuals associated with the contract Heneghan Way, Rockville, MD 20850. BILLING CODE 4140–01–P proposals, the disclosure of which Contact Person: Shamala K. Srinivas, would constitute a clearly unwarranted Ph.D., Scientific Review Officer, Office of invasion of personal privacy. Referral, Review, and Program Coordination, DEPARTMENT OF HEALTH AND Division of Extramural Activities, National Name of Committee: National Institute of Cancer Institute, NIH, 9609 Medical Center HUMAN SERVICES Allergy and Infectious Diseases Special Drive, Room 7W530, Bethesda, MD 20892– Emphasis Panel; Evaluation and Testing 9750, 240–276–6442, ss537t@nih.gov. National Institutes of Health Services for Vaccines and Other Biologics for Name of Committee: National Cancer National Cancer Institute; Notice of Diseases (N01). Institute Special Emphasis Panel Cancer Charter Renewal Date: November 14, 2017. Center Support Grant (P30). Time: 12:00 p.m. to 4:00 p.m. Date: December 1, 2017. Agenda: To review and evaluate contract Time: 2:30 p.m. to 4:15 p.m. It is determined that the National Agenda: To review and evaluate grant Cancer Institute Board of Scientific proposals. applications. Advisors is in the public interest in Place: National Institutes of Health, 5601 Place: Cambria Suites, Rockville, 1 Helen connection with the performance of Fishers Lane, Rockville, MD 20892 Heneghan Way, Rockville, MD 20850. duties imposed on the National Cancer (Telephone Conference Call). Contact Person: Adriana Stoica, Ph.D., Institute and National Institutes of Contact Person: Annie Walker-Abbey, Scientific Review Officer, Resources and Health by law, and that these duties can Ph.D., Scientific Review Officer, Scientific Training Review Branch, Division of Review Program, NIAID/NIH/DHHS, 5601 Extramural Activities, National Cancer best be performed through the advice Institute, NIH, 9609 Medical Center Drive, and counsel of this group. Fishers Lane, Room 3E70A, Rockville, MD 20852, 240–627–3390, aabbey@niaid.nih.gov. Room 7W234, Bethesda, MD 20892–9750, In accordance with Title 41 of the 240–276–6368, Stoicaa2@mail.nih.gov. (Catalogue of Federal Domestic Assistance U.S. Code of Federal Regulations, (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, Program Nos. 93.392, Cancer Construction; Section 102–3.65(a), notice is hereby and Transplantation Research; 93.856, given that the Charter for the National 93.393, Cancer Cause and Prevention Microbiology and Infectious Diseases Research; 93.394, Cancer Detection and Cancer Institute Board of Scientific Research, National Institutes of Health, HHS) Diagnosis Research; 93.395, Cancer Advisors was renewed for an additional Treatment Research; 93.396, Cancer Biology two-year period on October 8, 2017. Dated: October 17, 2017. Research; 93.397, Cancer Centers Support; Inquiries may be directed to Anna Natasha M. Copeland, 93.398, Cancer Research Manpower; 93.399, Snouffer, Acting Director, Office of Program Analyst, Office of Federal Advisory Cancer Control, National Institutes of Health, srobinson on DSKBC5CHB2PROD with NOTICES Committee Policy. HHS) Federal Advisory Committee Policy, Office of the Director, National [FR Doc. 2017–22825 Filed 10–19–17; 8:45 am] Dated: October 16, 2017. Institutes of Health, 6701 Democracy BILLING CODE 4140–01–P Melanie J. Pantoja, Boulevard, Suite 1000, Bethesda, Program Analyst, Office of Federal Advisory Maryland 20892 (Mail code 4875), Committee Policy. Telephone (301) 496–2123, or [FR Doc. 2017–22729 Filed 10–19–17; 8:45 am] snouffea@od.nih.gov. BILLING CODE 4140–01–P VerDate Sep<11>2014 16:22 Oct 19, 2017 Jkt 244001 PO 00000 Frm 00047 Fmt 4703 Sfmt 9990 E:\FR\FM\20OCN1.SGM 20OCN1


Document Created: 2017-10-20 00:06:39
Document Modified: 2017-10-20 00:06:39
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesNovember 14, 2017.
FR Citation82 FR 48832 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR